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considered as a source of malaria because of their high incidence
all over the year.
Conclusion: The quality of epidemiological data is discussed
regarding the provision and access to health services. Case reports
show weaknesses for some remote areas and at the end of each
year. Thepersistenceofmalaria on the coast could induce the emer-
gence of malaria in Central Highlands following reintroduction by
travelers.
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Background: Malaria infection during pregnancy, although
preventable and treatable, still has adverse effects on both the
mother and fetus in Nigeria. These adverse effects; intrauter-
ine growth retardation, low birth weight and maternal anemia
are signiﬁcant risk factors for neonatal and infant mortality. The
2014 national guidelines and strategies for control of malaria
during pregnancy recommend administration of at least 3 doses
of Sulphadoxine-Pyrimethamine (SP) as Intermittent Preventive
Treatment in pregnancy (IPTp) to pregnantwomen attendingAnte-
natal Care Clinic (ANC). However, implementation of the guidelines
is still sub-optimal. The objective of the study was to assess the
effect of scaled implementation of prevention of malaria in preg-
nancy (MiP) with IPTp on birth weight of babies born in states
supported by the US President’s Malaria Initiative.
Methods & Materials: The study used secondary data collected
from July 2013 to June 2015 in 7 states where routine ANC data
from all the health facilities are reported through the National Dis-
trict Health Information System to analyze trend and differences in
reported birth weight following implementation of IPTp with SP.
The interventions provided by the project include capacity build-
ing on control of malaria in pregnancy; strengthening of logistics
management systems for SP, monitoring and supportive supervi-
sion.
Results: Between July 2014 and June 2015, 636,600 health facil-
ity ANC visits and 191,104 births were reported. The observed
trend in the available data showed that the birth weight of babies
improved as the IPTp uptake increased. Mean percentage of ANC
revisits who received IPTp2 increased from 29% to 38%; the mean
percentage of babies with low birth weight decreased from 14% to
10%;while themean percentage of babies with birthweight higher
than 2,500g increased from 86% to 90% between the previous year
and the intervention period.
Conclusion: Though many confounders might contribute to
the improved birth weight of babies reported within the period,
however the contribution of the scaled implementation of IPTp
is signiﬁcant as previously documented in other malaria endemic
countries. Concerted efforts are needed to scale up this interven-
tion nationwide and strengthen health system in order to improve
the birth weight of babies and consequently reducing neonatal and
infant mortality.
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Background: Rickettsial infections are known to present mim-
icking autoimmune disorders. The gold standard diagnostic test for
rickettsial diseases is based on the detection of IgM and or IgG anti-
bodies against these infections by immuno-ﬂuorescent technique
(IFA). While conﬁrmation of rickettsial diseases warrant demon-
stration of rising or declining antibody titres between acute and
convalescent samples, high titres of either IFA-IgM or IFA-IgG in
acute phase serum in patients with a compatible clinical illness
may help in the presumptive diagnosis and introduction of anti-
rickettsial antibiotics. During the IFA test, patient sera containing
anti rickettsial antibodies are made to react with rickettsial anti-
gens that are grown in cell culture media. However, presence of
nuclear material in these cell cultures may react with anti-nuclear
antibodies that are produced in autoimmune disorders and cause
a false positive immunoﬂuorescent signal.
Methods&Materials: In order to evaluate the reactivity of rick-
ettsial disease IFA-IgG test [IFA-IgG-OT (Orientia tsutsugamushi) and
IFA-IgG-SFG (spotted fever group)] among patients with autoim-
mune diseases, an analytical cross-sectional study was carried out
using sera of 38 patients with conﬁrmed auto-immune diseases.
Results: The 38 patients included 15 systemic lupus
erythematosus (SLE), 5 autoimmune-thyroiditis, 13 idiopathic-
thrombocytopenia (ITP), 4 autoimmune-haemolytic-anaemia
(AIHA), 1 polymyositis, 1 polyglandular syndrome and 1 Anti-
phospholipid syndrome. The IFA-IgG reactivity of ≥ 1:128 was
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noted in 14/38 (37%); IFA-IgG-SFG in 7, IFA-IgG-OT in 3 and for
both in 4. Of the 14; titre of 1:128 in 2, 1:256 in 4, 1:512 in 5, >1:
1024 in 3 and 8/14 (57%) were SLE, 3/14 (21.4%%) were ITP, 2/14
(14.3%) were AIHA, 1/14 (7.1%) were polymyositis and none were
thyroiditis. 8/14 had received anti-rickettsial antibiotics during
the early stages of illness based on the clinical presentation and
high IFA-IgG titres.
Conclusion: Therewas a signiﬁcant reactivity of Rickettsial dis-
ease IFA-IgG assay in auto-immune diseases. Further studies are
needed in order to ascertainwhether this is due to recent rickettsial
infections, false positive cross reactivity of autoimmune antibod-
ies with rickettsial antigens or with cell culture nuclear antigens.
We did not carry out IFA-IgM due to non-availability and non-
affordability.
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Background: Rickettsia sp. causes rickettsioses, which despite
being among the oldest known arthropod-borne diseases, are
now recognized as important emerging vector-borne infections of
humans worldwide. In Kenya, the prevalence of these diseases is
poorly understood leading to far-reaching public health implica-
tions such as the unexplained fevers problem, some of which are
caused by different spotted fever group (SFG) rickettsiae.
Methods & Materials: We used a multi-genic approach to
identify rickettsia from 4,324 questing ticks (209 adult ticks, 586
nymphs and3,502 larvae) processed into 270pools of varying sizes,
dependingon species and life-cycle stages.Weﬁrst performedPCR-
high resolution melting point (HRM) based on Rickettsia 16S rRNA
gene followed by sequencing of unique melt proﬁles. Sequences
were identiﬁed by comparisons using BLASTn method. Thereafter,
we re-ampliﬁed and sequenced citrate synthase (gltA) and outer
membrane protein B (ompB) genes, as well as the highly variable
rpmE-tRNAfMet intergenic spacer for samples with unique rick-
ettsial 16S amplicon HRM proﬁles.
Results: We report the molecular detection of Rickettsia africae
in Amblyomma eburneum ticks and novel Rickettsia-like species in
Rhipicephalus maculatus ticks for the ﬁrst time. We detected R.
africae DNA with 99-100% identity for all the ampliﬁed gene loci
while identities of two Rickettsia-like species could not be ascer-
tained due to identical similarities associated with more than one
Rickettsia species across the ampliﬁed gene loci. Sequence analysis
of gltA gene for these two Rickettsia-like species showed 98% iden-
tity across severalRickettsia sp.The ompBgene couldnot amplify for
one of the species which also had 97% identity with R. bellii based
on the rpmE-tRNAfMet intergenic spacer sequence.
Conclusion: The detection of R. africae, an important emerging
pathogen in Sub-Saharan Africa as well as novel Rickettsia sp. with
unknown pathogenicity in this study represent signiﬁcant ﬁndings
that may explain the occurrence of some unidentiﬁed febrile ill-
nesses contributing to human morbidity. Additionally, our study
outlines the indispensable role of molecular methods in routine
surveillance to monitor both known and novel pathogens likely to
be emerging threats.
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Background: Kala-azar elimination initiative launched in 2005
in South Asia aims to reach the target by 2017. Early diagnosis and
effective treatment is one of the key strategies for control along
with integrated vector management. Single dose Ambisome (SDA)
and combination regimens are the recommended treatments in
South Asia. Our objective was to assess feasibility of using these
treatments within the public health facilities and document 12
month outcome.
Methods & Materials: This was an open label, prospective,
non-randomised, non-comparative, multicentric trial conducted at
public health facilities. The study was conducted from Aug 2012
to Sep 2015 at 02 districts (Vaishali and Saran) in Bihar and at
kala-azar referral hospital (Rajendra Memorial Research Institute
of Medical Sciences) in Patna.
In Vaishali district, patients were treated with SDA (10mg/kg)
at the District hospital and A+M (single dose Ambisome 5mg/kg +
miltefosine 7 days) at 5 primary healthcare centres (PHC). In Saran
District, M+P (Miltefosine and Paromomycin) for 10 days at district
hospital and 3 PHC.
All patientswere followedup to document outcomeat 6months
and cohort of them were followed for 12 months.
Results: 1761 patients were treated in the study, achieved cure
rate of > 99% at initial outcome (Day 10) in each treatment arm.
The cure rates at 6 months were 90.9% (95% CI 89.0-92.8) for SDA
(n=892), 88.8% (CI 85.5-92.1) for A+M (n=357) and 97.0% (CI 95.6-
98.5) for M+P arm (n=512). During 12 month FU (n=1386) there
were 11 additional relapses, 2 in SDA (n=706) and 6 in A+M (n=294)
and 3 inM+P (n=386). 12 patients developed PKDL inM+P arm, 1 in
A+M arm and 2 in SDA. Five SAE occurred in SDA arm, 2 considered
related and 3 non-related to Ambisome, all of them resolved.
